Research Article
A Prognostic Model Based on Six Metabolism-Related Genes in Colorectal Cancer
Table 1
The grouping of patients.
| | Variables | Training () | Validation () | | Cases (percentage) | Cases (percentage) |
| | Age | | ≤60 | 90 (29.41%) | 48 (37.50%) | | >60 | 216 (70.59%) | 80 (62.50%) | | Gender | | Female | 127 (41.50%) | 68 (53.13%) | | Male | 179 (58.50%) | 60 (46.88%) | | Tumor stage | | Stage I | 51 (16.67%) | 26 (20.31%) | | Stage II | 118 (38.56%) | 41 (32.03%) | | Stage III | 84 (27.45%) | 35 (27.34%) | | Stage IV | 41 (13.40%) | 23 (17.97%) | | NA | 12 (3.92%) | 3 (2.34%) | | T stage | | T1+Tis/T1 | 10 (3.27%) | 3 (2.34%) | | T2 | 53 (17.32%) | 27 (21.09%) | | T3 | 210 (68.63%) | 87 (67.97%) | | T4 | 33 (10.78%) | 11 (8.59%) | | N stage | | N0 | 178 (58.17%) | 74 (57.81%) | | N1 | 73 (23.86%) | 34 (26.56%) | | N2 | 44 (14.83%) | 30 (23.44%) | | Nx | 1 (0.33%) | \ | | M stage | | M0 | 230 (75.16%) | 96 (75.00%) | | M1 | 40 (13.07%) | 23 (17.97%) | | Mx | 31 (10.13%) | 8 (6.25%) | | NA | 5 (1.63%) | 1 (0.78%) |
|
|
